CC
FOLD

Carlson Capital’s Amicus Therapeutics FOLD Stock Holding History

Carlson Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,000
Closed -$607K – 81
2026
Q1 		$607K Buy
+42,000
New +$602K 0.19% 59

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carlson Capital's FOLD Position: Q2 2026 in Review

Carlson Capital sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 42,000 shares — an estimated $607K sold.

Carlson Capital first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $607K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Carlson Capital reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Carlson Capital sold 42,000 Amicus Therapeutics shares in Q2 2026, an estimated $607K.
  • Carlson Capital first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Carlson Capital's Amicus Therapeutics position peaked at $607K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Carlson Capital's 13F filing for Q2 2026, filed 12 Aug 2026.